Onconova Therapeutics, Inc. Warrants
ONTXW
ONTXW was delisted on the 23rd of July, 2021.
5 hedge funds and large institutions have $654K invested in Onconova Therapeutics, Inc. Warrants in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less funds holding
Funds holding: 6 → 5 (-1)
57% less capital invested
Capital invested by funds: $1.5M → $654K (-$850K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$285K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.25K |
ONTXW Hedge Fund Activity: Q2 2017 in Review
5 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q2 2017, worth a combined $654K — down 57% from $1.5M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ONTXW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Anson Funds Management, exiting entirely with an estimated $285K sold.
- 5 institutional investors held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q2 2017, down from 6 in Q1 2017.
- Funds reported $654K of Onconova Therapeutics, Inc. Warrants stock for Q2 2017, down 57% quarter-over-quarter.
- 0 funds opened new Onconova Therapeutics, Inc. Warrants positions in Q2 2017 and 1 closed out, a net change of -1 holder.
- The largest Onconova Therapeutics, Inc. Warrants seller in Q2 2017 was Anson Funds Management, an estimated $285K sold.
Based on aggregated 13F filings for Q2 2017.